Search
Site Logo
Back
Asset Type: White Papers

Impact of PET on Imaging Related Endpoints in Lymphoma Trials

Impact of PET on Imaging Related Endpoints in Lymphoma Trials
divider

In this whitepaper, experts discuss how PET imaging is critical in determining response assessments in hematology trials and what to do when PET scans are not always available.

Read the White Paper

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

"*" indicates required fields

By subscribing, you consent to receive emails from Perceptive. We respect your privacy and you can manage your communication preferences anytime. You can find the Perceptive privacy policy.

This field is for validation purposes and should be left unchanged.

© Perceptive 2024. All Rights Reserved.
Do Not Sell or Share My Personal Information